Description

• General description: A certified solution standard suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, or pharmaceutical research. 4′-Hydroxydiclofenac is a major metabolite of diclofenac, a COX-2 inhibitor used for the treatment of minor aches, pains, and fever.
• Application: Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs): This study examines the biotransformation of 4′-Hydroxydiclofenac by Streptomyces griseolus CYP105A1, emphasizing its relevance in pharmacokinetic research on drug metabolism and enzyme inhibition studies (Yogo et al., 2022).A multi-biomarker approach to assess toxicity of diclofenac and 4-OH diclofenac: Investigates the environmental impact of 4′-Hydroxydiclofenac on molluscs, providing insights into the ecological side-effects of pharmaceutical residues and their metabolites, important for researchers studying drug metabolism and environmental safety (Swiacka et al., 2022).Cytochrome P450 Expression and Chemical Metabolic Activity before Full Liver Development in Zebrafish: Highlights the role of 4′-Hydroxydiclofenac in early developmental stages of liver metabolism in zebrafish, useful for developmental pharmacokinetics and toxicology studies (Nawaji et al., 2020).Different Roles of Human Cytochrome P450 2C9 and 3A Enzymes in Diclofenac 4′- and 5-Hydroxylations: Explores the specific roles of cytochrome P450 enzymes in the metabolism of diclofenac and its major metabolite 4′-Hydroxydiclofenac, offering critical insights for pharmacokinetic research and drug metabolism assays (Miura et al., 2020).
• Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany